The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK DIRECTOR DEALINGS SUMMARY: Braveheart Buys Stake In RMS From Brown

Wed, 01st Jul 2020 17:15

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Tuesday and Wednesday and not separately reported by Alliance News:

----------

Remote Monitored Systems PLC - London-based majority owner of GyroMetric Systems Ltd, which provides digital monitoring and safeguarding systems for rotating shafts on wind turbines - Braveheart Investment Group PLC buys 119.6 million shares from Executive Director Trevor Brown at 0.275 pence, worth GBP329,003, on Tuesday. Brown is chief executive officer of Braveheart, and payment for the RMS shares is in new Braveheart shares issued to Brown. Following the transaction, Braveheart owns 18.1% of RMS, and Brown has no interest. Brown now has a 24.8% stake in Braveheart. RMS owns 58% of GyroMetric and Braveheart owns 19.5%. Brown will remain on the RMS board to represent Braveheart.

----------

Savills PLC - London-based estate agent - James Sparrow, CEO of Savills UK & EMEA, sells 4,096 shares at GBP8.33, worth GBP34,100, on Friday last week. Still holds 58,475 shares.

----------

Babcock International Group PLC - London-based engineering services for defence - Chair Ruth Cairnie and associate buy 10,000 shares in total at GBP3.12 and GBP3.15, worth GBP31,333, on Wednesday.

----------

Qinetiq Group PLC - Farnborough, Hampshire-based security and defence contractor - Non-Executive Director Susan Searle buys 10,000 shares at GBP3.0244, worth GBP30,244, on Wednesday.

----------

Walker Greenbank PLC - Denham, Buckinghamshire-based interior furnishings - Non-Executive Director Christopher Rogers buys 52,500 shares at 37p, worth GBP19,425, on Tuesday. Now has 75,000 shares.

----------

Renew Holdings PLC - Leeds-based engineering services for infrastructure - Non-Executive Director Shatish Dasani and wife Dina buy 10,000 shares total at 444p, worth GBP44,400, on Tuesday. Dasani now interested in 15,000 shares.

----------

Staffline Group PLC - Nottingham-based recruitment and training firm - Three directors buy GBP70,857 in shares on Tuesday. Executive Chair Ian Lawson buys 131,577 shares at 39.00p, worth GBP51,315. Interim Chief Financial Officer Daniel Quint buys 25,320 shares at average 39.49p, worth GBP9,209. Non-Executive Director Richard Thomson buys 25,857 shares at average 39.96p, worth GBP10,333.

----------

Solid State PLC - Redditch, Worcestershire-based electronic components - Finance Director Peter James buys 2,520 shares at GBP5.95, worth GBP14,994. Now has 3,204 shares. Matthew Richards, managing director of subsidiary Steatite Ltd, buys 2,900 shares at GBP5.91, worth GBP17,126. Now has 10,375 shares. Both on Tuesday.

----------

ECSC Group PLC - Bradford-based cybersecurity firm - CEO Ian Mann buys 29,827 shares at average 67p, worth GBP19,984, on Wednesday. Now has 2.3 million shares, a 23% stake.

----------

Redx Pharma PLC - Macclesfield-based cancer and fibrosis drugs - Non-Executive Chair Iain Ross buys 215,870 shares at average 18.94p, worth GBP40,886, on Tuesday. Non-Executive Director Peter Presland buys 118,849 shares at 25p, worth GBP29,712, also on Tuesday. Both purchases are their only holdings.

----------

Trackwise Designs PLC - Tewkesbury, Gloucestershire-based printed circuit technology - Non-Executive Director Charles Cattaneo buys 10,000 shares at 86p, worth GBP8,600, on Tuesday. The shares are his only holding.

----------

UIL Ltd - closed-end Bermuda-incorporated investment company - Non-Executive Director Stuart Bridges buys 6,080 shares at 180p, worth GBP10,944, on Wednesday.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
11 Mar 2020 10:23

Redx Pharma Optimistic As Loss Narrows And Cancer Trial Progresses

Redx Pharma Optimistic As Loss Narrows And Cancer Trial Progresses

Read more
28 Feb 2020 18:47

UPDATE: Redx Pharma To Get GBP26 Million Injection Amid No Yesod Bid

UPDATE: Redx Pharma To Get GBP26 Million Injection Amid No Yesod Bid

Read more
28 Feb 2020 18:08

No Redx Pharma Takeover As Yesod Opts Not To Make Offer

No Redx Pharma Takeover As Yesod Opts Not To Make Offer

Read more
14 Feb 2020 17:11

UK Regulator Extends Deadline For Possible Redx Pharma Cash Offer

UK Regulator Extends Deadline For Possible Redx Pharma Cash Offer

Read more
28 Jan 2020 14:15

UK Regulator Extends Deadline For Possible Redx Pharma Cash Offer

UK Regulator Extends Deadline For Possible Redx Pharma Cash Offer

Read more
24 Jan 2020 11:51

Moulton Goodies Raises Stake In Redx Pharma To 42% From 18%

Moulton Goodies Raises Stake In Redx Pharma To 42% From 18%

Read more
9 Jan 2020 16:02

Redx Pharma nominates next drug development candidate

(Sharecast News) - Drug discovery and development company Redx Pharma announced the nomination of RXC007 as its next drug development candidate for the treatment of fibrosis on Thursday.

Read more
9 Jan 2020 11:17

Redx Pharma Nominates Another Anti-Fibrosis Drug Candidate

Redx Pharma Nominates Another Anti-Fibrosis Drug Candidate

Read more
31 Dec 2019 10:34

UK WINNERS & LOSERS SUMMARY: Redx Surges On Potential Takeover Offer

UK WINNERS & LOSERS SUMMARY: Redx Surges On Potential Takeover Offer

Read more
31 Dec 2019 09:12

Redx Pharma Shares Soar On Discussions Over Possible Takeover Offer

Redx Pharma Shares Soar On Discussions Over Possible Takeover Offer

Read more
31 Dec 2019 08:51

LONDON MARKET OPEN: Stocks Start Mostly Lower Amid Profit Taking

LONDON MARKET OPEN: Stocks Start Mostly Lower Amid Profit Taking

Read more
19 Nov 2019 12:29

Redx collaboration with MDC awarded Innovate UK funding

(Sharecast News) - Redx Pharma announced on Tuesday that Innovate UK has awarded biomedical catalyst funding to Redx and Medicines Discovery Catapult (MCD).

Read more
19 Nov 2019 11:53

Redx Pharma Secures Funding To Develop Lung Condition Therapies

Redx Pharma Secures Funding To Develop Lung Condition Therapies

Read more
19 Aug 2019 10:22

Redx Pharma Gets Approval To Escalate Dose In RXC004 Study

(Alliance News) - Redx Pharma PLC on Monday said it has successfully completed dosing of the first cohort of patients in its ongoing phase 1/2 study with RXC004.RXC004 is an oral porcupine

Read more
19 Aug 2019 09:43

Redx Pharma gets green light to escalate dose in RXC004 study

(Sharecast News) - Drug discovery and development company Redx Pharma has successfully completed dosing of the first cohort of patients in its ongoing phase 1 and 2 study with 'RXC004', it announced on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.